Position in ABBV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$170,005,625
-$8,283,065 QoQ
Shares Held
781,671
+0.2% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.99208490528623.ToString("F0")%
Shared 0.ToString("F0")%
None 3.0079150947137605.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. ABBV ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
555,104 | $510,568,006 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
781,671 | $170,005,625 | |
| 3 | AZN |
Astrazeneca PLC
|
821,571 | $162,030,232 | |
| 4 | NVO |
Novo Nordisk A S
|
1,790,627 | $65,805,542 | |
| 5 | NVS |
Novartis AG
|
311,008 | $47,506,472 | |
| 6 | JNJ |
Johnson & Johnson
|
179,177 | $43,798,025 | |
| 7 | MRK |
Merck & Co., Inc.
|
157,451 | $18,939,780 | |
| 8 | GSK |
GSK plc
|
33,346 | $1,840,365 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $170,005,625 | 781,671 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $178,288,690 | 780,291 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $173,457,727 | 749,148 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $133,463,193 | 719,013 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $150,264,810 | 717,186 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $120,243,370 | 676,665 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $133,531,236 | 676,176 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $19,787,919 | 115,368 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $21,008,512 | 115,368 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $17,785,596 | 114,768 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $16,913,540 | 113,468 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $15,284,175 | 113,443 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $17,784,576 | 111,593 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,233,947 | 156,141 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $20,972,459 | 156,266 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $30,014,918 | 195,971 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,316,211 | 365,901 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $49,488,835 | 365,501 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $39,444,499 | 365,667 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $41,188,730 | 365,667 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $39,594,343 | 365,869 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $39,202,863 | 365,869 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $32,046,465 | 365,869 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $35,921,018 | 365,869 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $27,872,282 | 365,826 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||